Role of clinical pharmacist in the management of blood pressure in dialysis patients

International Journal of Clinical Pharmacy

Volumn 38, Issue 4, 2016, Pages 931-940

  Qudah, Bonyan ^a   Albsoul Younes, Abla ^a,c,d   Alawa, Ezat ^a   Mehyar, Nabil ^b  

^a UNIVERSITY OF JORDAN   (Jordan)

^b Isra'a Hospital   (Jordan)

^c Hamdi Mango Center for Scientific Research   (Jordan)

^d JORDAN UNIVERSITY HOSPITAL   (Jordan)

Author keywords

Dialysis; Hypertension; Jordan; Pharmaceutical care

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; COUNSELING; DIASTOLIC BLOOD PRESSURE; FEMALE; HEMODIALYSIS PATIENT; HOME MONITORING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACIST; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WEIGHT GAIN; DISEASE MANAGEMENT; HEMODIALYSIS; MIDDLE AGED; PHYSICIAN; PROFESSIONAL STANDARD; PUBLIC RELATIONS; RANDOMIZED CONTROLLED TRIAL;

BLOOD PRESSURE MONITORING, AMBULATORY; DISEASE MANAGEMENT; FEMALE; HUMANS; HYPERTENSION; INTERPROFESSIONAL RELATIONS; MALE; MIDDLE AGED; PHARMACISTS; PHYSICIANS; PROFESSIONAL ROLE; RENAL DIALYSIS;

EID: 84971657247     PISSN: 22107703     EISSN: 22107711     Source Type: Journal    
DOI: 10.1007/s11096-016-0317-2     Document Type: Article

References (26)

1. Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med. 2003;115(4):291–7.
2. Agarwal R. Blood pressure and mortality among hemodialysis patients. Hypertension. 2010;55(3):762–8.
3. Dzgoeva FU, Gatagonova TM, Kadzaeva ZK, Khamitsaeva OV, Kochisova ZK, Dzutseva AT, et al. Left ventricular hypertrophy in end-stage renal disease and its possible regression as a result of correction of anemia and arterial hypertension. Terapevticheskii Arkhiv. 2011;83(6):42–6.
4. Campese VM, Vidhun J, Park J. Hypertension in Dialysis Patients. In: Henrich William L, editor. Principles and practice of dialysis. Philadelphia: Lippincott Williams & Wilkins; 2009. p. 289–316.
5. Da Silva GV, de Barros S, Abensur H, Ortega KC, Mion D Jr. Cochrane renal group prospective trial register: CRG060800146. Home blood pressure monitoring in blood pressure control among haemodialysis patients: an open randomized clinical trial. Nephrol Dial Transpl. 2009;24(12):3805–11.
6. Agarwal R, Brim NJ, Mahenthiran J, Andersen MJ, Saha C. Out-of-hemodialysis-unit blood pressure is a superior determinant of left ventricular hypertrophy. Hypertension. 2006;47(1):62–8.
7. Moriya H, Oka M, Maesato K, Mano T, Ikee R, Ohtake T, et al. Weekly averaged blood pressure is more important than a single-point blood pressure measurement in the risk stratification of dialysis patients. Clin J Am Soc Nephrol. 2008;3(2):416–22. doi:10.2215/CJN.03490807.
8. Alborzi P, Patel N, Agarwal R. Home blood pressures are of greater prognostic value than hemodialysis unit recordings. Clin J Am Soc Nephrol. 2007;2(6):1228–34.
9. Agarwal R, Sinha AD, Light RP. Toward a definition of masked hypertension and white coat hypertension among hemodialysis patients. Clin J Am Soc Nephrol. 2011;6(8):2003–8. doi:10.2215/CJN.02700311.
10. Manley HJ, Garvin CG, Drayer DK, Reid GM, Bender WL, Neufeld TK, et al. Medication prescribing patterns in ambulatory hemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider. Nephrol Dial Transpl. 2004;19(7):1842–8.
11. Stemer G, Lemmens-Gruber R. Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review. BMC Nephrol. 2011;12:35. doi:10.1186/1471-2369-12-35.
12. Salgado TM, Moles R, Benrimoj SI, Fernandez-Llimos F. Pharmacists’ interventions in the management of patients with chronic kidney disease: a systematic review. Nephrol Dial Transpl. 2012;27(1):276–92.
13. Santschi V, Chiolero A, Colosimo AL, Platt RW, Taffé P, Burnier M, et al. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2014;3(2):e000718.
14. Bonso E, Dorigatti F, Palatini P. Accuracy of the BP A100 blood pressure measuring device coupled with a single cuff with standard-size bladder over a wide range of arm circumferences. Blood Press Monit. 2009;14(5):216–9.
15. Agarwal R, Lewis R. Prediction of hypertension in chronic hemodialysis patients. Kidney Int. 2001;60:1982–9.
16. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(4 Suppl 3):S1–153.
17. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.
18. Morgado MP, Morgado SR, Mendes LC, Pereira LJ, Castelo-Branco M. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis. Am J Health Syst Pharm. 2011;68(3):241–53.
19. Albsoul-Younes AM, Hammad EA, Yasein NA, Tahaineh LM. Pharmacist-physician collaboration improves blood pressure control. Saudi Med J. 2011;32(3):288–92.
20. Hammad EA, Yasein N, Tahaineh L, Albsoul-Younes AM. A randomized controlled trial to assess pharmacist- physician collaborative practice in the management of metabolic syndrome in a university medical clinic in Jordan. J Manag Care Pharm. 2011;17(4):295–303.
21. Mehos BM, Saseen JJ, MacLaughlin EJ. Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy. 2000;20(11):1384–9.
22. St Peter WL, Farley TM, Carter BL. Role of collaborative care models including pharmacists in improving blood pressure management in chronic kidney disease patients. Curr Opin Nephrol Hypertens. 2011;20(5):498–503.
23. El Borolossy R, El Wakeel L, El Hakim I, Badary O. Implementation of clinical pharmacy services in a pediatric dialysis unit. Pediatr Nephrol. 2014;29(7):1259–64. doi:10.1007/s00467-014-2760-4.
24. Machado M, Bajcar J, Guzzo GC. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007;41:1770–81.
25. López-Gómez JM, Villaverde M, Jofre R, Rodriguez-Benítez P, Pérez-García R. Interdialytic weight gain as a marker of blood pressure, nutrition, and survival in hemodialysis patients. Kidney Int Suppl. 2005;93:S63–8.
26. Inrig JK, Patel UD, Gillespie BS, Hasselblad V, Himmelfarb J, Reddan D, et al. Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients. Am J Kidney Dis. 2007;50(1):108–18.